Relenza 5 mg
Relenza 5 mg is a medicine authorised by Swissmedic under authorisation number 55108. The authorisation holder is GlaxoSmithKline AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 24 June 1999 and the authorisation is valid without a time limit. ATC code J05AH01 places the medicine in the group Antivirals for systemic use.
| Authorisation number | 55108 |
|---|---|
| Name | Relenza 5 mg |
| Full name | Relenza 5 mg, Disk (Pulverinhalation) |
| Authorisation holder | GlaxoSmithKline AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | J05AH01 |
| First authorisation | 24 June 1999 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Relenza 5 mg, Disk (Pulverinhalation) | B | 24 June 1999 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 20 | Einzeldose(n) | J05AH01 | 08.03.0. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Relenza 5 mg authorised in Switzerland?
Yes. Relenza 5 mg is authorised by Swissmedic under authorisation number 55108, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Relenza 5 mg have?
Relenza 5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Relenza 5 mg?
The authorisation holder is GlaxoSmithKline AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.